Hikma Pharmaceuticals (HKMPY) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hikma Pharmaceuticals

    OTC: HKMPY · Real-Time Price · USD
    49.25
    -0.15 (-0.30%)
    At close: Oct 03, 2025, 12:19 PM
    49.25
    0.00%
    Pre-market: Oct 03, 2025, 09:44 AM EDT

    Hikma Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 369.66M 357.66M 284.53M 189.53M 146.73M 188.73M 347.61M 422.61M 463.08M
    Depreciation & Amortization
    		 206.98M 201.98M 196.25M 190.25M 197.75M 194.75M 182.83M 167.83M 147.73M
    Stock-Based Compensation
    		 16M 15M 30M 25M 22M 22M 23M 29M 29M
    Other Working Capital
    		 114.38M 67M 114M 131M 3.6M -51.4M 10.78M 84.78M 7.77M
    Other Non-Cash Items
    		 -128.64M 23.27M 149.71M 500.71M 800.21M 717.21M 577.05M 486.05M 540.23M
    Deferred Income Tax
    		 n/a n/a -125.08M -456.08M -528.51M -497.51M -495.72M -479.72M -580.5M
    Change in Working Capital
    		 -11.64M -109.64M -28.64M 79.36M -107.41M -137.41M -96.28M -30.28M -248.27M
    Operating Cash Flow
    		 452.37M 488.27M 506.76M 528.76M 530.76M 487.76M 538.49M 595.49M 351.26M
    Capital Expenditures
    		 -162.34M -163.34M -164.38M -202.38M -224.02M -236.02M -256.13M -231.13M -212.99M
    Cash Acquisitions
    		 -159.37M -160.37M -86.31M -86.31M -19.26M -391.26M -391.16M -17.16M -59.93M
    Purchase of Investments
    		 20.13K -1.98M -23.79M -26.79M -2.73M -15.73M -20.03M -3.03M 89.57K
    Sales Maturities Of Investments
    		 n/a n/a -7.95K 992.05K 1M n/a 6.06M 6.06M 1.96M
    Other Investing Acitivies
    		 -147.11M -33.23M -50.82M -22.82M -9.85M 3.15M 17.03M 3.03M -13.95M
    Investing Cash Flow
    		 -499.09M -389.22M -325.3M -337.3M -254.86M -639.86M -644.23M -242.23M -284.81M
    Debt Repayment
    		 209.75M 72.75M -74.26M -92.26M -211.92M 451.08M 609.23M -83.77M -1M
    Common Stock Repurchased
    		 -39.63M -37.62M n/a n/a -11.69M -311.69M -300M n/a 2.72M
    Dividend Paid
    		 -175.24M -173.24M -157.91M -135.91M -130.12M -131.12M -126.12M -121.12M -112.05M
    Other Financial Acitivies
    		 51.22M 34.05M 24.2M -24.8M -12.78M 5.22M -14.32M -34.32M -25.36M
    Financial Cash Flow
    		 46.1M -104.06M -207.97M -252.97M -366.51M 10.49M 165.79M -239.21M -144.36M
    Net Cash Flow
    		 n/a -17M -36M -65M -99M -156M 45M 99M -90M
    Free Cash Flow
    		 317.75M 353.75M 376.39M 326.39M 306.75M 251.75M 282.36M 364.36M 138.27M

    Add to Watchlist